Labiotech.eu

Single use plastics Bioplastics industry

In Depth 21 Jul 2021

What the EU’s Single-Use Plastics Ban Means for the Bioplastics Industry

A European directive banning a range of single-use plastics came into law this month. How are the new regulations impacting industrial biotech companies developing bioplastics? In an attempt to reduce staggeringly high levels of plastic pollution seen around the world, particularly in marine environments, the 27 EU member states and Norway agreed in 2019 to […]

July 21, 2021 - 10 minutesmins - By Helen Albert

danish biotech neurodegenerative alzheimers 1

News and Trends 20 Jul 2021

Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene

Muna Therapeutics debuted with the Danish biotech sector’s biggest-ever Series A round earlier this month. This showcases the rapid growth taking place in the biotech industry in the Nordic region. Muna Therapeutics’ €62M ($73M) investment was co-led by the Danish investor Novo Holdings through its early-stage arm Novo Seeds. The startup was first set up […]

July 20, 2021 - 4 minutesmins - By Victor Kotsev

IP intellectual property biotech startup

Expert Advice 19 Jul 2021

How to Protect Your Intellectual Property as a Biotech Startup

Biotechs always start with great scientific ideas, but if you can’t protect them, you can’t see them through to execution. Companies need to start developing long-term intellectual property strategies almost as early as they are devising the ideas that need protecting. Experts say that the right intellectual property (IP) strategy for a new biotech depends […]

July 19, 2021 - 9 minutesmins - By Mark Zipkin

uk vc firm investment biotech life sciences

News and Trends 16 Jul 2021

Multi-Million UK Life Sciences Initiative Welcomed By VC Firms

Biotech venture capital firms across Europe have warmly received the launch of a €235M (£200M) UK government initiative to support the growth of promising late-stage life sciences companies. The UK’s Life Sciences Investment Programme opened to applications from fund managers this month, with the aim of providing €235M in late-stage capital and attracting at least […]

July 16, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 14 Jul 2021

EMA Market Approval Rate for Small Biotechs Skyrocketed Last Year

The success rate for small biotechs applying for regulatory approval from the EMA has risen by over 100% since 2016, which analysts partly attribute to increased access to sophisticated technology and funding. According to a recent announcement from the EMA, the regulator greenlit a whopping 89% of applications for marketing authorization for new medicines from […]

July 14, 2021 - 3 minutesmins - By Victor Kotsev

Best in Biotech 14 Jul 2021

5 Easy DIY Biology Experiments You Can Do at Home

Here are five easy DIY biology experiments to have fun at home without the need for expensive laboratory equipment. Biology is fascinating, but not all of us have access to state-of-the-art laboratory equipment to do biology experiments. However, it is possible to do some simple experiments at home with the right materials. These DIY biology […]

July 14, 2021 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Jul 2021

Sofinnova Taps into Italian Gene Therapy with Three Seed Financings

The French investor Sofinnova Partners has injected a total of €6M into three Italian gene therapy companies, cementing Italy’s reputation as a European center for cell and gene therapies. Last month, the venture capitalist Sofinnova Partners used its Telethon fund to inject cash into AAVantgarde Bio, Borea Therapeutics, and Alia Therapeutics. The three firms will […]

July 12, 2021 - 5 minutesmins - By Anita Chakraverty

In Depth 12 Jul 2021

The Hidden Role of Biobanks in Covid-19 Research

Biobanks have played a key role in the fight against Covid-19 by allowing researchers to access the samples they needed to study the disease and develop vaccines and treatments. While the pandemic presented a big challenge to the often underfunded biobanks, it also provided an opportunity for growth in many other areas of research going […]

July 12, 2021 - 7 minutesmins - By Carlos de Rojas

News and Trends 8 Jul 2021

The Top European Biotech Funding Rounds in June

While oncology and psychedelics dominated European biotech’s biggest funding rounds last month, startup seed financing focused more on gene therapy and drug discovery. Last month saw some momentous events for Europe’s biotech heavyweights. GSK paid an impressive €524M ($625M) upfront to co-develop an immuno-oncology candidate with iTeos Therapeutics in Belgium. Meanwhile, the German antibody drug […]

July 8, 2021 - 5 minutesmins - By Jonathan Smith

Antoine Papiernik Sofinnova Partners Biotech Entrepreneurs

Opinion 7 Jul 2021

Three Lessons an Investor Can Learn from Biotech Entrepreneurs

Sofinnova Partners’ Chairman and Managing Partner, Antoine Papiernik, describes his company’s ‘Wall of Fame’ showcasing its entrepreneurs and how their years of experience provide a source of inspiration for venture capitalists. Every time I walk through our Paris office, I am greeted by a wall of photos showcasing some of the top entrepreneurial minds that […]

July 7, 2021 - 7 minutesmins - By Antoine Papiernik

Expert Advice 5 Jul 2021

Why the Right Team is Key for Biotech Success

For any startup, and especially for biotechnology startups, success depends on three main factors: science, financing, and people. One of the key factors investors look for is having a management team that can raise money and make good use of it to advance the science of the company. According to Sinclair Dunlop, Managing Partner at […]

July 5, 2021 - 7 minutesmins - By External Contributor

poxel diabetes Sumitomo Dainippon Pharma

News and Trends 2 Jul 2021

Poxel’s Diabetes Drug Wins Japan Nod, But Competition Remains Fierce

As French biotech Poxel marks the first market approval of its oral type 2 diabetes medication in Japan, eyes turn to the future of this drug and its rivals in Europe and the US. The fortunes of the Lyon-based Poxel have been boosted by the first-ever regulatory approval of its oral type 2 diabetes medication […]

July 2, 2021 - 5 minutesmins - By Anita Chakraverty

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

What the EU’s Single-Use Plastics Ban Means for the Bioplastics Industry

Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene

How to Protect Your Intellectual Property as a Biotech Startup

Multi-Million UK Life Sciences Initiative Welcomed By VC Firms

EMA Market Approval Rate for Small Biotechs Skyrocketed Last Year

5 Easy DIY Biology Experiments You Can Do at Home

Sofinnova Taps into Italian Gene Therapy with Three Seed Financings

The Hidden Role of Biobanks in Covid-19 Research

The Top European Biotech Funding Rounds in June

Three Lessons an Investor Can Learn from Biotech Entrepreneurs

Why the Right Team is Key for Biotech Success

Poxel’s Diabetes Drug Wins Japan Nod, But Competition Remains Fierce

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!